Walleye Capital’s AEON Biopharma Inc AEON.WS Stock Holding History

Walleye Capital’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-39,549	Closed	-$57.3K	–	6198
2024 Q1	$57.3K	Sell	39,549 -25,400	-39%	-$15.6K	﹤0.01%	4635
2023 Q4	$4.87K	Buy	64,949 +15,500	+31%	+$1.16K	﹤0.01%	4657
2023 Q3	$7.42K	Buy	49,449 +21,200	+75%	+$3.01K	﹤0.01%	4524
2023 Q2	$2.54K	Hold	28,249	–	–	﹤0.01%	4129
2023 Q1	$1.55K	Buy	+28,249	New	+$1.63K	﹤0.01%	3808

Walleye Capital's AEON.WS Position: Q2 2024 in Review

Walleye Capital sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 39,549 shares — an estimated $57.3K sold.

Walleye Capital first reported a position in AEON.WS in Q1 2023 and held it in 5 quarters. The position peaked at $57.3K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Walleye Capital reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Walleye Capital sold 39,549 AEON Biopharma Inc shares in Q2 2024, an estimated $57.3K.
Walleye Capital first reported a position in AEON Biopharma Inc in Q1 2023 and held it in 5 quarters.
Walleye Capital's AEON Biopharma Inc position peaked at $57.3K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.